Core Scientific Inc (CORZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | 6,849 | -12,206 |
| Depreciation Amortization | 3,459 | 10,703 |
| Accounts receivable | -6,600 | N/A |
| Accounts payable and accrued liabilities | -1,792 | N/A |
| Other Working Capital | 14,102 | -21,127 |
| Other Operating Activity | -606 | -1,135 |
| Operating Cash Flow | $15,412 | $-23,765 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -10,757 | -1,568 |
| Net Acquisitions | N/A | -13,668 |
| Other Investing Activity | -16 | 92 |
| Investing Cash Flow | $-10,773 | $-15,144 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 22,220 | N/A |
| Debt Repayment | -1,683 | N/A |
| Common Stock Issued | 496 | N/A |
| Other Financing Activity | 0 | 40,723 |
| Financing Cash Flow | $21,033 | $40,723 |
| Beginning Cash Position | 8,721 | 6,907 |
| End Cash Position | 34,393 | 8,721 |
| Net Cash Flow | $25,672 | $1,814 |
| Free Cash Flow | ||
| Operating Cash Flow | 15,412 | -23,765 |
| Capital Expenditure | -10,757 | N/A |
| Free Cash Flow | 4,655 | -23,765 |